Browse treatments

…monstrated that TA-1 or anti-PD-1 inhibited tumor growth, while combination therapy led to greater tumor inhibition.Additionally, we established ad…

…-intensity statin and 32.6% of these achieved their LDL-C goal. Combination therapy was prescribed to 9.3% of participants. In multivariate analysi…

…I) remains a key issue in cardiovascular disease. Historically, combination therapy, comprising oral anticoagulation (OAC) with antiplatelet agents…

…, all-cause mortality (HR=1.36 (1.23–1.51)), and progression to combination therapy (HR=3.22 (3.04–3.41)) or insulin (HR=3.21 (2.89–3.55)).Conclusi…

…type 2 diabetes.All classes were associated with progression to dual therapy and to insulin. Class F (“rapid decrease”) had the lowest estim…

…mmatory, metabolic, and antigen presentation pathways. In vivo, combination therapy significantly reduced tumor burden, extended survival, and pola…

…o have achieved sustained remission, including those undergoing combination therapy, holds significant importance for both clinicians and patients.…